|Last Price$45.65||Day Change (%)-1.50%|
|Open Price$46.33||Day Change ($)-0.70|
|Day Range45.58–46.37||52-Week Range36.65–47.88|
As of Wed 4/1/2015 3:22:00 PM | USD
UPDATE: Analog Devices gains on upgrade; Altera slides
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Research and Markets: Germany Healthcare, Regulatory and Reimbursement Landscape Report 2015
Mylan N.V. Announces Pricing of Secondary Public Offering of a Portion of Abbott's Ordinary Shares
Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares
Simple formulas for foreign exposure lose luster.
Abbott Labs ABT had a strong showing at the American College of Cardiology's annual meeting this weekend, but the news was less positive for Boston Scientific BSX and partner Angiotech ANPI. Abbott revealed data from a head-to-head trial that demonstrated its Xience V drug-eluting stent performed ...
Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States
AbbVie And C2N Enter Into A Worldwide License Agreement For Alzheimer's Disease Therapy
Research and Markets: Australia Sleep Apnea Diagnostic Systems Market Growth Trends Report 2015